Cargando…
The Intestinal Microbiome Predicts Weight Loss on a Calorie-Restricted Diet and Is Associated With Improved Hepatic Steatosis
Background: The microbiome has been shown in pre-clinical and epidemiological studies to be important in both the development and treatment of obesity and metabolic associated fatty liver disease (MAFLD). However, few studies have examined the role of the microbiome in the clinical response to calor...
Autores principales: | Dong, Tien S., Luu, Kayti, Lagishetty, Venu, Sedighian, Farzaneh, Woo, Shih-Lung, Dreskin, Benjamin W., Katzka, William, Chang, Candace, Zhou, Yi, Arias-Jayo, Nerea, Yang, Julianne, Ahdoot, Aaron I., Ye, Jason, Li, Zhaoping, Pisegna, Joseph R., Jacobs, Jonathan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295485/ https://www.ncbi.nlm.nih.gov/pubmed/34307440 http://dx.doi.org/10.3389/fnut.2021.718661 |
Ejemplares similares
-
A High Protein Calorie Restriction Diet Alters the Gut Microbiome in Obesity
por: Dong, Tien S., et al.
Publicado: (2020) -
Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease
por: Dong, Tien S., et al.
Publicado: (2021) -
The Ocular Microbiome Is Altered by Sampling Modality and Age
por: Katzka, William, et al.
Publicado: (2021) -
A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD
por: Dong, Tien S., et al.
Publicado: (2020) -
Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease
por: Dong, Tien S., et al.
Publicado: (2023)